-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

641.O1.6 641. CLL: Biology and Pathophysiology, excluding Therapy: Genetic Models and Genomic Landscape of CLL and Richter Transformation

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Leukemia, apoptosis, Animal models, CLL, Non-Biological, cell division, Diseases, Lymphoma (any), Therapies, Elderly, Biological Processes, Technology and Procedures, Xenograft models, cytogenetics, epigenetics, gene editing, Study Population, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, pharmacology, NGS, RNA sequencing, pathogenesis, WGS, pathways
Monday, December 7, 2020: 11:30 AM-1:00 PM
Moderators:
Dimitar G Efremov, MD, PhD, International Center for Genetic Engineering and Biotechnology and Davide Rossi, MD, PhD, Istituto Oncologico della Svizzera Italiana (IOSI)
Disclosures:
Efremov: Janssen-Cilag International: Speakers Bureau. Rossi: Beigene: Honoraria; Janssen: Honoraria, Research Funding; AbbVie: Honoraria, Research Funding; AstraZenecs: Honoraria, Research Funding.
11:30 AM

Elisa Ten Hacken, PhD1,2, Tomasz Sewastianik, PhD3,4*, Robert A. Redd, MS5*, Geoffrey Fell, PhD6*, Mohamed Uduman, PhD5*, Michaela Gruber, MD, PhD7,8,9,10*, Shanye Yin, PhD7*, Kendell Clement, PhD1,10,11*, Erin Michelle Parry, MD, PhD7,12, Shuqiang Li, PhD10,13*, Maria Hernandez-Sanchez, PhD14*, Leah Billington, BA7*, Elizabeth Witten7*, Kaitlyn J Baranowski7*, Lili Wang, MD, PhD15, Luca Pinello, PhD1,10,11*, Kenneth J. Livak, PhD13*, Donna S. Neuberg, ScD16, Ruben D. Carrasco, MD, PhD1,4,17* and Catherine J. Wu, MD1,7,10,18

1Harvard Medical School, Boston, MA
2Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
3Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
4Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Dana-Farber Cancer Institute, Boston, MA
7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, A - 1090 Vienna, AUT
9CeMM, Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
10Broad Institute of MIT and Harvard, Cambridge, MA
11Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA
12Department of Medical Oncology, Brigham & Women's Hospital/Massachusetts General Hospital, Boston, MA
13Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
14Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain
15Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA
16Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA
17Dept. of Pathology, Brigham and Women's Hospital, Boston, MA
18Department of Internal Medicine, Brigham and Women’s Hospital, Boston, MA

11:45 AM

Binyamin A. Knisbacher, PhD1*, Ziao Lin, BS1,2*, Cynthia K. Hahn, MD, PhD1,3*, Ferran Nadeu4,5*, Martí Duran-Ferrer4,5*, Kristen E. Stevenson, MS6*, Eugen Tausch, MD7*, Alex Barbera-Mourelle1,8*, Andrew Dunford1*, Shankara Anand1*, Julio Delgado, MD4,5,9, Julian M. Hess1*, Amaro Taylor-Weiner, PhD1*, Helene Kretzmer, PhD10*, Pablo Bousquets Muñoz11*, Conner J. Shaughnessy12*, Stacey M. Fernandes, BS3,13*, Mariela Sivina14*, Laura Z. Rassenti, PhD15, Alexander Meissner, PhD1,10,16*, Adrian Wiestner, MD, PhD17, Jan A. Burger, MD, PhD18, Thomas J. Kipps, MD, PhD15, Jennifer R Brown, MD, PhD2,12, Michael Hallek19,20,21, François Aguet, PhD1*, Donna S. Neuberg, ScD6, Xose S Puente, PhD11*, Chip Stewart, PhD1*, José I. Martín-Subero, PhD4,5,22,23*, Stephan Stilgenbauer, MD24,25, Catherine J. Wu, MD1,2,3,26, Elías Campo, MD, PhD4,5,23,27 and Gad Getz, PhD1,2,8,28*

1Broad Institute of MIT and Harvard, Cambridge, MA
2Harvard Medical School, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
5Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
6Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
7Department of Internal Medicine III, Ulm University, Ulm, Germany
8Center for Cancer Research, Massachusetts General Hospital, Boston, MA
9Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, Spain
10Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany
11Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain
12Dana-Farber Cancer Institute, Boston, MA
13Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
14Department of Leukemia, UT M.D. Anderson Cancer Center, Houston, TX
15Moores Cancer Center, University of California, San Diego, La Jolla, CA
16Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
17Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
18Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
19Center for Molecular Medicine, Cologne, Germany
20Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group, University of Cologne, Cologne, Germany
21Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
22Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
23Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
24Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany
25Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
26Department of Internal Medicine, Brigham and Women’s Hospital, Boston, MA
27Hematopathology Section, Laboratory of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain
28Department of Pathology, Massachusetts General Hospital, Boston, MA

12:00 PM

Miguel Quijada Álamo, MSc1,2*, Maria Hernandez-Sanchez, PhD1,2,3*, Ana E. Rodriguez, PhD1,2*, Claudia Pérez Carretero, MSc, BSc1,2*, Marta Martín Izquierdo, MSc1,2*, Verónica Alonso Pérez, PhD1,2*, Ignacio García-Tuñón, PhD2,4*, Jose Maria Bastida, MD, PhD2*, Maria Jesus Vidal, MD5*, Josefina Galende DEL Canto, MD6*, Carlos Aguilar, MD7*, José Antonio Queizán, MD8*, Isabel González-Gascón Y Marín, MD, PhD9*, Jose-Angel Hernandez, MD, PhD9*, Rocio Benito, PhD1,2*, José Luis Ordóñez, PhD1,2* and Jesus Maria Hernández-Rivas, MD, PhD1,10

1University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain
2Department of Hematology, University Hospital of Salamanca, Salamanca, Spain
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, Salamanca, Spain
5Department of Hematology, Hospital Virgen Blanca, Leon, Spain
6Department of Hematology, Hospital del Bierzo, Ponferrada, Spain
7Department of Hematology, Hospital Santa Bárbara, Soria, Spain
8Department of Hematology, Hospital General de Segovia, Segovia, Spain
9Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain
10Department of Hematology, University Hospital of Salamanca, IBSAL, Salamanca, Spain

12:15 PM

Bo Zhang, MD, PhD1, Prajish Iyer, PhD2*, Meiling Jin, PhD3*, Elisa Ten Hacken, PhD4, Zachary Cartun, BS4*, Kevyn Hart, BS3*, Laura Z. Rassenti, PhD5, Thomas J. Kipps, MD, PhD6, Donna S. Neuberg, ScD7, Ruben D. Carrasco, MD, PhD8*, Catherine J. Wu, MD9 and Lili Wang, MD, PhD3

1Department of Systems Biology, NCI Comprehensive Cancer Center, Beckman Research Institute | City of Hope, 1218 South 5th Avenue, Monrovia, CA, 91016, Monrovia, CA
2Systems Biology Department, City of Hope National Medical Centre, Monrovia, CA
3Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA
4Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
5Moores Cancer Center, University of California, San Diego, La Jolla, CA
6UCSD Moores Cancer Center, San Diego, CA
7Data Sciences Institute, Dana Farber, Boston
8Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

12:30 PM

Supriya Chakraborty, PhD1*, Claudio Martines, MS1*, Fabiola Porro, MS1*, Ilaria Fortunati, BS1*, Alice Bonato, BA1*, Marija Dimishkovska, PhD2*, Brijesh Yadav, PhD3*, Idanna Innocenti, MD, PhD4*, Rosa Fazio, BA1*, Tizianna Vaisitti, PhD5, Silvia Deaglio, MD5, Alberto Zamò, MD, PhD6*, Aleksandar Dimovski, MD, PhD2*, Luca Laurenti, MD4* and Dimitar G Efremov, MD, PhD7

1Molecular Hematology, International Center for Genetic Engineering and Biotechnology, Trieste, Italy
2RCGEB, Macedonian Academy of Sciences and Arts, Skopje, MKD
3University of Information Science and Technology "St. Paul the Apostle", Ohrid, MI, Macedonia, The former Yugoslav Republic of
4Institute of Hematology, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Rome, Italy
5Department of Medical Sciences, University of Turin, Torino, Italy
6Institute of Pathology, University of Würzburg, Würzburg, Germany
7Molecular Hematology Unit, International Center for Genetic Engineering and Biotechnology, Trieste, Italy

12:45 PM

Claudia Pérez Carretero, MSc, BSc1,2*, Miguel Quijada Álamo, MSc1,2*, Maria Hernandez-Sanchez, PhD1,2*, Ana E. Rodriguez, PhD1,2*, Ana B Herrero, PhD3,4*, Jesus M Hernández-Sánchez, PhD2,5*, Marta Martín Izquierdo, MSc1*, Teresa González, PhD2*, Sandra Santos-Mínguez1,2*, Cristina Miguel-García6*, Araceli Rubio-Martínez7*, Alfonso García de Coca, MD, PhD8*, Julio Dávila9*, Jose-Angel Hernandez, MD, PhD10*, Rocio Benito, PhD1,2*, José Luis Ordóñez, PhD3,4* and Jesus Maria Hernández-Rivas, MD, PhD11

1Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain
2Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain
3University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain
4Department of Hematology, University Hospital of Salamanca, Salamanca, Spain
5IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, Salamanca, Spain
6Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain
7Servicio de Hematología, Hospital Miguel Servet, Zaragoza, Spain
8Servicio de Hematología, Hospital Clínico, Valladolid, Spain
9Departamento de Hematología, Hospital Nuestra Señora de Sónsoles, Ávila, Spain
10Hematology Department, Hospital Infanta Leonor, Madrid, Spain
11Hospital Universitario de Salamanca, Salamanca, Spain

*signifies non-member of ASH